Item 8.01 Other Events.
On January 6, 2020, Daniel J. O'Connor, President, CEO and Director of OncoSec
Medical Incorporated ("OncoSec" or the "Company"), issued a letter to
shareholders and related press release highlighting both leading independent
proxy advisory firms, ISS and Glass Lewis, have recommended OncoSec shareholders
vote FOR the proposed strategic transaction with Grand Decade Developments
Limited, a British Virgin Islands limited company and a wholly owned subsidiary
of China Grand Pharmaceutical and Healthcare Holdings Limited and its U.S.
affiliate, Sirtex Medical US Holdings, Inc. on the WHITE proxy card at the
upcoming special meeting of stockholders of the Company scheduled to be held on
January 17, 2020.
A copy of the press release that includes the letter to OncoSec shareholders is
furnished as Exhibit 99.1 hereto.
Item 9.01 Financial Statements and Exhibits.
The following exhibit is furnished as part of this report:
Exhibit
Number Description
99.1 Press Release dated January 6, 2020.
2
© Edgar Online, source Glimpses